DKTK Translational Advisory Board (TAB)
The DKTK TAB is a new panel of international experts that supports the evaluation of project proposals within the Joint Funding Program since 2025.
Members:
- I. Hartung (Merck Healthcare, Darmstadt)
- D. Heenen (Kickcancer, Brüssel)
- M. van der Heijden (Netherlands Cancer Institute, Amsterdam)
- B. Möckel (QIAGEN GmbH, Hilden)
- K. Pantel (Universitätsklinikum Hamburg-Eppendorf, Hamburg)
- R. Pfeiffer (National Cancer Institute NIH, Bethesda, MD)
- M. Röhrl (Beth Israel Deaconess Medical Center, Boston, MA)
- E. Sala (Università Cattolica del Sacro Cuore, Rome)
- R. Schulze (SMS Sachsen, Dresden)
- B. Singers Sørensen (Aarhus University Hospital, Aarhus)
- P. Staber (Saarland University Medical School, Homburg/Saar, and Medical University of Vienna, Wien)
- J. Stingl (UKHD, Heidelberg)
- K. Tasken (Oslo University Hospital, Oslo)